Ethical trade-offs in vaccine development and distribution-Response to Gurwitz

doi:10.1016/j.vaccine.2021.01.020

Comment

. 2021 Feb 12;39(7):1028-1029.

doi: 10.1016/j.vaccine.2021.01.020.

Ethical trade-offs in vaccine development and distribution-Response to Gurwitz

Annette Rid¹, Seema K Shah², Franklin G Miller³, Marion Danis⁴, Marie Nicolini⁵, Jorge Ochoa⁶, Holly A Taylor⁷, David S Wendler⁸, Christine Grady⁹

Affiliations

¹ Department of Bioethics, National Institutes of Health Clinical Center, Building 10/1C118, NIH, Bethesda, MD 20892, United States. Electronic address: annette.rid@nih.gov.
² Lurie Children's Hospital, Northwestern University Department of Pediatrics, 225 E. Chicago Ave, Chicago, IL 60611, United States. Electronic address: Seshah@lurie.childrens.org.
³ Weill Cornell Medical College, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065, United States. Electronic address: fgm2002@med.cornell.edu.
⁴ Department of Bioethics, National Institutes of Health Clinical Center, Building 10/1C118, NIH, Bethesda, MD 20892, United States. Electronic address: mdanis@nih.gov.
⁵ Department of Bioethics, National Institutes of Health Clinical Center, Building 10/1C118, NIH, Bethesda, MD 20892, United States. Electronic address: marie.nicolini@nih.gov.
⁶ Department of Bioethics, National Institutes of Health Clinical Center, Building 10/1C118, NIH, Bethesda, MD 20892, United States. Electronic address: jorge.ochoa@nih.gov.
⁷ Department of Bioethics, National Institutes of Health Clinical Center, Building 10/1C118, NIH, Bethesda, MD 20892, United States. Electronic address: holly.taylor2@nih.gov.
⁸ Department of Bioethics, National Institutes of Health Clinical Center, Building 10/1C118, NIH, Bethesda, MD 20892, United States. Electronic address: dwendler@cc.nih.gov.
⁹ Department of Bioethics, National Institutes of Health Clinical Center, Building 10/1C118, NIH, Bethesda, MD 20892, United States. Electronic address: cgrady@nih.gov.

PMID: 33546811
PMCID: PMC9756567
DOI: 10.1016/j.vaccine.2021.01.020

Comment

Ethical trade-offs in vaccine development and distribution-Response to Gurwitz

Annette Rid et al. Vaccine. 2021.

. 2021 Feb 12;39(7):1028-1029.

doi: 10.1016/j.vaccine.2021.01.020.

Authors

Annette Rid¹, Seema K Shah², Franklin G Miller³, Marion Danis⁴, Marie Nicolini⁵, Jorge Ochoa⁶, Holly A Taylor⁷, David S Wendler⁸, Christine Grady⁹

Affiliations

¹ Department of Bioethics, National Institutes of Health Clinical Center, Building 10/1C118, NIH, Bethesda, MD 20892, United States. Electronic address: annette.rid@nih.gov.
² Lurie Children's Hospital, Northwestern University Department of Pediatrics, 225 E. Chicago Ave, Chicago, IL 60611, United States. Electronic address: Seshah@lurie.childrens.org.
³ Weill Cornell Medical College, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065, United States. Electronic address: fgm2002@med.cornell.edu.
⁴ Department of Bioethics, National Institutes of Health Clinical Center, Building 10/1C118, NIH, Bethesda, MD 20892, United States. Electronic address: mdanis@nih.gov.
⁵ Department of Bioethics, National Institutes of Health Clinical Center, Building 10/1C118, NIH, Bethesda, MD 20892, United States. Electronic address: marie.nicolini@nih.gov.
⁶ Department of Bioethics, National Institutes of Health Clinical Center, Building 10/1C118, NIH, Bethesda, MD 20892, United States. Electronic address: jorge.ochoa@nih.gov.
⁷ Department of Bioethics, National Institutes of Health Clinical Center, Building 10/1C118, NIH, Bethesda, MD 20892, United States. Electronic address: holly.taylor2@nih.gov.
⁸ Department of Bioethics, National Institutes of Health Clinical Center, Building 10/1C118, NIH, Bethesda, MD 20892, United States. Electronic address: dwendler@cc.nih.gov.
⁹ Department of Bioethics, National Institutes of Health Clinical Center, Building 10/1C118, NIH, Bethesda, MD 20892, United States. Electronic address: cgrady@nih.gov.

PMID: 33546811
PMCID: PMC9756567
DOI: 10.1016/j.vaccine.2021.01.020

No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Comment on

Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries.
Gurwitz D. Gurwitz D. Vaccine. 2021 Feb 12;39(7):1027. doi: 10.1016/j.vaccine.2021.01.015. Vaccine. 2021. PMID: 33546810 Free PMC article. No abstract available.

References

1. Gurwitz D. Ethical tradeoffs in SARS-CoV-2 vaccine development: assuring fair availability for low-income countries [letter under consideration at Vaccine]. - PMC - PubMed
1. Bollyky TJ, Bown CP. The tragedy of vaccine nationalism. Foreign Affairs, September/October 2020. Available from: foreignaffairs.com/articles/united-states/2020-07-27/vaccine-nationalism...
1. World Health Organization. COVAX – Working for global equitable access to COVID-19 vaccines. Available from: who.int/initiatives/act-accelerator/covax
1. World Health Organization: WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination, 14 September 2020. Available from” apps.who.int/iris/handle/10665/334299
1. Liu Y., Salwi S., Drolet B.C. Multivalue ethical framework for fair global allocation of a COVID-19 vaccine. J Med Ethics. 2020;46(8):499–501. - PMC - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Gurwitz D. Ethical tradeoffs in SARS-CoV-2 vaccine development: assuring fair availability for low-income countries [letter under consideration at Vaccine]. - PMC - PubMed

[2] Gurwitz D. Ethical tradeoffs in SARS-CoV-2 vaccine development: assuring fair availability for low-income countries [letter under consideration at Vaccine]. - PMC - PubMed

[3] Bollyky TJ, Bown CP. The tragedy of vaccine nationalism. Foreign Affairs, September/October 2020. Available from: foreignaffairs.com/articles/united-states/2020-07-27/vaccine-nationalism...

[4] Bollyky TJ, Bown CP. The tragedy of vaccine nationalism. Foreign Affairs, September/October 2020. Available from: foreignaffairs.com/articles/united-states/2020-07-27/vaccine-nationalism...

[5] World Health Organization. COVAX – Working for global equitable access to COVID-19 vaccines. Available from: who.int/initiatives/act-accelerator/covax

[6] World Health Organization. COVAX – Working for global equitable access to COVID-19 vaccines. Available from: who.int/initiatives/act-accelerator/covax

[7] World Health Organization: WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination, 14 September 2020. Available from” apps.who.int/iris/handle/10665/334299

[8] World Health Organization: WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination, 14 September 2020. Available from” apps.who.int/iris/handle/10665/334299

[9] Liu Y., Salwi S., Drolet B.C. Multivalue ethical framework for fair global allocation of a COVID-19 vaccine. J Med Ethics. 2020;46(8):499–501. - PMC - PubMed

[10] Liu Y., Salwi S., Drolet B.C. Multivalue ethical framework for fair global allocation of a COVID-19 vaccine. J Med Ethics. 2020;46(8):499–501. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Ethical trade-offs in vaccine development and distribution-Response to Gurwitz

Affiliations

Ethical trade-offs in vaccine development and distribution-Response to Gurwitz

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical